-
Study aim
-
Determining the effect of 24 and 48 hours replacement of sodium chloride serum used in drug infusion on the rate of infection and phlebitis
-
Design
-
Clinical trial with control group, with parallel groups, double-blind, randomized, on 300 patients. Permutation blocks were used for randomization.
-
Settings and conduct
-
Participants are selected from patients admitted to the internal medicine and surgery wards of Shirvan Hospital and are randomly assigned to the experimental and control groups.
Due to the nature of the study, it is not possible to blind the participants.
The researcher records the time and date of placement of the serum and catheter, and every 6 hours the site will be monitored for phlebitis.
In the experimental and control groups, serum will be changed 48 and 24 hours, respectively.
At the end of these times, some of the serum is sterilized and sent to a laboratory where it is cultured by a blind laboratory expert. After 48 hours, if more than fifteen colonies of microbial growth are seen in each sample, the result is positive culture and infectious serum. Blind statistics are analyzed.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: People over the age of 18, patient consent or guardian, patient cooperation, having a drug to be infused, patients who are hospitalized for at least 48 hoursNo entry conditions:
Pregnant, lactating, immunocompromised patients
Suffering from skin and vascular diseases
Patients receiving hypertonic substances and blood and its products, TPN solution
Patients with sepsis and mental disorders
Receiving anticoagulants
If you have a local infection at the catheter injection site
-
Intervention groups
-
in the control group, the serum used in the infusion of drugs will be changed every 24 hours and in the intervention group every 48 hours.
-
Main outcome variables
-
Phlebitis, serum contamination